Feedback / Questions
SP-002 - Stamford Pharma
https://www.prnewswire.com/news-releases/stamford-pharmaceuticals-inc-announces-the-first-patient-to-be-treated-with-sp-002-in-combination-with-erivedge-in-a-phase-2-study-in-locally-advanced-bcc-subjects-302113772.html
Apr 11, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next